NCT07000656 Micturition Desire-Relaxation Training Device for Lower Urinary Tract Dysfunction in Children
| NCT ID | NCT07000656 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai Children's Medical Center |
| Condition | Daytime Urinary Incontinence |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-11-20 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-11-20 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Urine storage and voiding are fundamental physiological processes. In clinical settings, many cases of lower urinary tract dysfunction (LUTD) are closely associated with abnormal conditioned reflexes formed in the central nervous system during the urine storage or voiding phases. Relaxation, as a core physiological and psychological state, has been shown to promote effective urine storage and facilitate smooth voiding. By repeatedly training individuals to establish a new conditioned reflex linking the sensation of urinary urgency with a state of relaxation, it may be possible to improve bladder storage capacity and voiding function. Based on this concept, the investigators have developed the world's first Micturition Desire-Relaxation Training Device (Chinese Patent No.: ZL 2020 1 0397789.4). This study aims to evaluate the clinical efficacy of this device in treating LUTD in children.
Eligibility Criteria
Inclusion Criteria: 1. Diagnosis according to the ICCS criteria: For nocturnal enuresis: At least one episode of involuntary nighttime urination per month for more than 3 months. No abnormalities in routine urinalysis. No period of bedwetting-free days lasting more than 6 months, except for organic diseases. For daytime urinary incontinence: At least one episode of intermittent urinary leakage during wakefulness per month for more than 3 months. No anatomical or neurological causes of urinary incontinence. For urinary frequency: The child experiences only urinary frequency and urgency, occurring during the day and before sleep, with intervals ranging from a few minutes to 1 hour. Each urination involves a small volume, less than 50% of the estimated bladder capacity \[EBC (mL) = 30 + (age × 30)\], typically less than 30 mL, sometimes just a few drops, while total daily urine volume remains within normal limits. When the child is engaged in play or focused, the intervals between urination are extended, and urinary frequency symptoms disappear after falling asleep. 2. Age: 5 to 18 years (inclusive), regardless of gender. 3. Voluntary participation: The child and their guardian must voluntarily participate in the trial and sign the informed consent form. Exclusion Criteria: 1. Exclude enuresis caused by urinary tract infections, pinworms, myelitis, spinal cord injuries, epilepsy, cerebral developmental disorders, diabetes, and other neurological, urinary, or endocrine diseases, as well as transient enuresis due to excessive activity, mental fatigue, or excessive fluid intake before bedtime. 2. Exclude conditions causing urinary frequency such as neurogenic bladder, urinary tract infections, urethral syndrome, hypercalciuria, or metabolic diseases. 3. Patients who have participated in or are currently participating in other clinical trials within the past month. 4. Patients deemed unsuitable for participation in the clinical trial by the investigator.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07000656 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 18 Years, studying Daytime Urinary Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07000656 currently recruiting?
Yes, NCT07000656 is actively recruiting participants. Contact the research team at majun@shsmu.edu.cn for enrollment information.
Where is the NCT07000656 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07000656 clinical trial?
NCT07000656 is sponsored by Shanghai Children's Medical Center. The trial plans to enroll 200 participants.